Zscaler Inc
—- Market cap
- —
- Debt
- —
- Cash
- −$928.35M
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: ZS stock price vs ROP: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at ROP's multiple
Needs ROP P/S.
Implied fair value · at ZS's multiple
Needs ZS P/S.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Nine period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Zscaler Inc · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
ROPER TECHNOLOGIES, INC. · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Palo Alto Networks Inc
ZS vs PANW
CrowdStrike Holdings, Inc.
ZS vs CRWD
Okta, Inc.
ZS vs OKTA
Cloudflare, Inc.
ZS vs NET
Fortinet, Inc.
ZS vs FTNT
HONEYWELL INTERNATIONAL INC
ZS vs HON
EMERSON ELECTRIC CO
ZS vs EMR
Fortive Corp
ZS vs FTV
Keysight Technologies, Inc.
ZS vs KEYS
METTLER TOLEDO INTERNATIONAL INC/
ZS vs MTD
Vontier Corp
ZS vs VNT
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe ZS can rapidly convert its 23.3% revenue growth and 76.9% gross margin into sustained operating and net profitability, then hold or add selectively because the current multiple could be justified by future margin expansion; otherwise, the valuation looks stretched versus ROP and the implied price points to meaningful downside.
ZS trades at a much richer sales multiple than ROP despite the comparison implying a lower value, with current price $168.68 versus an implied $85.01, or -49.6% downside. The gap is driven by ZS's 10.2x P/S and 9.7x EV/Revenue versus ROP's 5.0x P/S and 6.3x EV/Revenue, while ZS also has negative earnings and much weaker operating efficiency.
Supporting Metrics